Monsenso ASOCSE:MONSO +4.57%29 FCF Margin % is -83.43% as of Dec. 2025. GuruFocus rates OCSE:MONSO with a GF Score™ of 29/100 and a GF Value™ of kr0.15 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Monsenso AS ranks worse than 86.7% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Monsenso AS's Free Cash Flow for the
six
months ended in Dec. 2025 was kr-3.12 Mil. Monsenso AS's Revenue for the
six
months ended in Dec. 2025 was kr3.74 Mil. Therefore, Monsenso AS's FCF Margin % for the quarter that ended in Dec. 2025 was -83.43%.
The historical rank and industry rank for Monsenso AS's FCF Margin % or its related term are showing as below:
OCSE:MONSO'
s FCF Margin % Range Over the Past 10 Years
Min: -218.94 Med: -50.51 Max: -2.44
Current: -40.75
During the past 9 years, the highest FCF Margin % of Monsenso AS was -2.44%. The lowest was -218.94%. And the median was -50.51%.
OCSE:MONSO's FCF Margin % is ranked worse than 86.7% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.39
vs OCSE:MONSO: -40.75
Monsenso AS FCF Margin % Related Terms
Monsenso AS FCF Margin % Historical Data
* Premium members only.
The historical data trend for Monsenso AS's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:MONSO vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, Monsenso AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monsenso AS FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Monsenso AS's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Monsenso AS's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monsenso AS (OCSE:MONSO) has a FCF Margin % of -83.43% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Monsenso AS and its competitors. According to the industry distribution chart, Monsenso AS ranks #580 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 86.7%.
Is Monsenso AS's FCF Margin % too high?
Monsenso AS's current FCF Margin % is -83.43%. Based on the distribution chart, Monsenso AS ranks #580 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Monsenso AS has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Monsenso AS's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Monsenso AS ranks #580 out of 669 companies for FCF Margin %. This places Monsenso AS in the lower half of its industry. The industry median FCF Margin % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Monsenso AS and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Monsenso AS's current FCF Margin % is -83.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monsenso AS stock overvalued right now?
Based on GuruFocus' analysis, Monsenso AS (OCSE:MONSO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.15, compared to a current price of kr0.37 — trading 144% above its estimated fair value. The current FCF Margin % is -83.43%. Monsenso AS's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Monsenso AS (OCSE:MONSO), the current FCF Margin % is -83.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monsenso AS (OCSE:MONSO) Overvalued in 2026?
Based on GuruFocus' analysis, Monsenso AS stock appears to be overvalued.
The current stock price of kr0.37 is trading 144% above its estimated GF Value™ of kr0.15.
GuruFocus considers Monsenso AS to be Significantly Overvalued.
Key valuation signals for OCSE:MONSO:
FCF Margin %: -83.43%
GF Value™: kr0.15 vs. price of kr0.37 (144% above fair value)
No single metric tells the full story. See the OCSE:MONSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. The company's mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data, and the solution helps optimise the treatment and gives a detailed overview of an individual's health through the collection of outcome, adherence, and behavioral data.
29GF Score
Get the complete analysis for OCSE:MONSO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:MONSO has been successfully added to your 
